Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-04

Clinical Trial Update: Role of Liquid Phase Concentrated Growth Factors vs. Hypertonic Dextrose Prolotherapy for Management of Patients With Disc Displacement Without Reduction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing liquid phase concentrated growth factors versus hypertonic dextrose prolotherapy for temporomandibular joint disorders with dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hypertonic dextrose prolotherapy
  • liquid phase concentrated growth factors

Snippet

Sponsor: Nourhan M.Aly | Conditions: Temporomandibular Joint Disorders, Temporomandibular Disorder | Phase 2 | Status: COMPLETED